SB-200646

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rjwilmsi (talk | contribs) at 16:59, 17 December 2016 (→‎top: Journal cites, Added 1 doi to a journal cite using AWB (12130)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

SB-200646
Clinical data
ATC code
  • none
Legal status
Legal status
  • UN: Unscheduled
Identifiers
  • 1-(1-Methyl-1H-indol-5-yl)-3-pyridin-3-ylurea
PubChem CID
ChemSpider
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H14N4O
Molar mass302.76 g/mol g·mol−1
3D model (JSmol)
  • Cn1ccc2c1ccc(c2)NC(=O)Nc3cccnc3
  • InChI=1S/C15H14N4O/c1-19-8-6-11-9-12(4-5-14(11)19)17-15(20)18-13-3-2-7-16-10-13/h2-10H,1H3,(H2,17,18,20)
  • Key:OJZZJTLBYXHUSJ-UHFFFAOYSA-N

SB-200646 is a 5-HT2 receptor antagonist with anxiolytic properties in rats. It was the first 5-HT2 antagonist discovered to have selectivity of 5-HT2C/2B over 5-HT2A.[1]

References

  1. ^ Kennett, GA; Wood, MD; Glen, A; Grewal, S; Forbes, I; Gadre, A; Blackburn, TP (1994), "In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist", Br J Pharmacol, 111, British Journal of Pharmacology: 797–802, doi:10.1111/j.1476-5381.1994.tb14808.x, PMC 1910094, PMID 7912626